In vitro evolution of proteins for drug development.
Thanks to biotechnology, proteins are becoming increasingly important tools to fight disease, both as therapeutics in their own right and as catalysts for the synthesis of small molecule drugs. However, the properties of these proteins are not necessarily optimal for their intended tasks. In vitro evolution is a set of technologies useful to address their shortcomings. Moreover, in vitro evolution can help illuminate natural evolutionary pathways, thus potentially enabling prediction of drug resistance evolution. We consider here recent developments in the area of in vitro evolution, as well as its application to proteins of interest to medical science.
Delagrave
Simon
S
Center for Molecular Biotechnology, Fraunhofer USA, 9 Innovation Way, Suite 200, Newark, DE 19711, USA. sdelagrave@fraunhofer-cmb.org
Murphy
Dennis J
DJ
D001681:Biological Assay / Q000379:methods; D002384:Catalysis; D015195:Drug Design; D004364:Pharmaceutical Preparations / Q000138:chemical synthesis; D010600:Pharmacology; D011506:Proteins / Q000737:chemistry*; D013678:Technology, Pharmaceutical
D004364:Pharmaceutical Preparations; D011506:Proteins